Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research ... is downplayed in favor of focusing on the Spine segment, there is potential for joint ...

Nevro has about 1,100 employees, while Globus has more than 5,000 workers. Founded in 2006, Nevro has developed the patented HFX spinal cord stimulation platform for treating chronic pain of the ...

The company makes medical implants including plates, screws and anchors for spine ... bone grafts. Please watch the video at Investors.com - How To Buy Stocks: Flat Base Chart Pattern Globus ...